Histopathological finding | N (%) |
---|---|
Lung (49) | |
 Diffuse alveolar damage (DAD) | 44 (89.79) |
  Early DAD | 14 (28.57) |
  Proliferative or organising phase of DAD | 20 (40.81) |
  Late DAD | 10 (20.40) |
 Interstitial pneumonia | 4 (8.16) |
 Lung abscess | 1 (2.04) |
 Pulmonary oedema | 6 (12.24) |
 Microthrombi | 21 (42.85) |
 Hyaline membrane | 19 (39.77) |
 Type II pneumocyte hyperplasia | 15 (30.61) |
 Intra-alveolar hemorrhage | 12 (24.48) |
Myocardium (51) | |
 Focal myocardial hypertrophy | 39 (79.59) |
 Interstitial myocarditis | 2 (4.08) |
 Interstitial fibrosis | 8 (16.32) |
 Plasma cell and neutrophilic infiltration | 6 (12.24) |
Kidney (47) | |
 Cloudy degeneration of tubules | 24 (51.06) |
 Thyroidisation of tubules | 7 (14.89) |
 Tubular atrophy | 6 (12.76) |
 Glomerular congestion | 18 (38.29) |
 Mesangial proliferation | 12 (25.53) |
 Glomerulosclerosis | 7 (14.89) |
 Interstitial inflammation | 12 (25.53) |
 Hyaline arteriosclerosis | 9 (19.14) |
Liver (49) | |
 Hepatic sinusoidal dilatation and congestion | 29 (59.18) |
 Vacuolar degeneration | 22 (44.89) |
 Microvesicular fatty change | 18 (36.3) |
 Cholestasis | 5 (10.20) |
 Lymphocytic infiltration | 30 (61.22) |
 Central venous congestion | 14 (28.57) |
Spleen (46) | |
 Sinusoidal congestion | 22 (47.83) |
 Amyloidosis | 1 (2.17) |